PUBLISHER: Inkwood Research | PRODUCT CODE: 1069940
PUBLISHER: Inkwood Research | PRODUCT CODE: 1069940
The Asia-Pacific bone densitometer market is set to register a CAGR of 4.85% during the forecast period, 2022-2030. The surging population in countries like India and China and the growing life expectancy leading to increased geriatric population boost market growth in the region.
Australia & New Zealand, Japan, Singapore, China, South Korea, Indonesia, India, and Rest of Asia-Pacific are assessed for the Asia-Pacific bone densitometer market growth evaluation. Japan, the 'super-aged' society, has a fast-growing population. It is home to a whopping 80000 centenarians. Also, as per estimates, people over 65 are expected to constitute a third of the population by 2036. The country's demographic crisis is characterized by two elements, a low fertility rate and a high life expectancy. In addition, the market growth is attributed to strategic initiatives by companies. For instance, FUJIFILM Corporation announced an agreement with Hitachi Ltd to acquire the latter's Imaging-related business to expand its healthcare business.
The high bone densitometer growth rate in India is accredited to the increased life expectancy and population. Also, osteoporosis affects around 1.5 million men and almost 80% of women. Additionally, there are 150,000 HWCs (Health and Wellness Centers) established to enhance timely healthcare access. Besides, the country is adopting advanced technologies in healthcare, leading to growing investments by private and public organizations.
Indonesia is witnessing an increasing number of bone-related diseases and osteoporosis. Also, its healthcare system is gradually improving. In addition, the government is investing in healthcare services. Such aspects boost market growth opportunities in these countries.
Some of the eminent companies in the market include: Osteometer MediTech Inc, Medonica Co Ltd, Oscare Medical Oy, OSI Systems Inc, etc.